MMP-2 activity was strongly correlated with tumor invasiveness (r2 = 0.95) and could be inhibited by metalloprotease inhibitors or protein kinase C (PKC) inhibition via calphostin C, reducing invasion by >90%. This evidence concerns the gene MMP2 and neoplasm.